Skip to main content

and
  1. Article

    Open Access

    In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period

    SB12 is a biosimilar to eculizumab reference product [SolirisTM (Soliris is a trademark of Alexion Pharmaceuticals, Inc.)] that acts as a C5 complement protein inhibitor. The infusion stability of in-use (diluted...

    Minji Tak, Hawon Jeong, Jihoon Yun, Jihyun Kim, Soyeon Kim, Yoonsook Lee in Drugs in R&D (2023)